NEW YORK, June 29 (GenomeWeb News) - Researchers at the Instituto de Medicina Molecular in
The screen is based on an in vitro assay developed by Maria Mota's lab at the IMM that monitors the response of human liver cells to malaria infection. Dresden, Germany-based Cenix adapted Mota's assay for high-throughput RNAi screening, and a pilot study using the screen has been completed.
According to the two partners, a larger screen is now underway that "will cover over 800 human genes including all known kinases, key regulators of nearly all cellular pathways." They are also seeking additional funding to expand the capabilities of the assay, they said.